Prevalence of minimal hepatic encephalopathy in cirrhotic patients

Annals of Hepatology

Volumn 10, Issue SUPPL. 2, 2011, Pages

  Maldonado Garza, Héctor Jesús ^a   Vázquez Elizondo, Genaro ^a   Gaytán Torres, Juan Obed ^a   Flores Rendón, Ángel Ricardo ^a   Cárdenas Sandoval, Martha Graciela ^a   Bosques Padilla, Francisco Javier ^a  

^a HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

Author keywords

Critical flicker frequency; Educational level; Minimal hepatic encephalopathy; Psychometric hepatic encephalopathy score; Survival

Indexed keywords

ADULT; AGE; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CRITICAL FLICKER FUSION; DIAGNOSTIC TEST; EDUCATIONAL STATUS; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; INCIDENCE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; PSYCHOMETRY; PSYCHOMETRY HEPATIC ENCEPHALOPATHY SCORE; STATISTICAL ANALYSIS;

EID: 79961188840     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31605-9     Document Type: Article

References (34)

1. Bosetti C, Levi F, Lucchini F, Zatonski WA, Negri E, La Vecchia C. Worldwide mortality from cirrhosis: an update to 2002. J Hepatol 2007; 46: 827-39
2. Principales causas de mortalidad en edad productiva (de 15 a 64 años), periodo 2000 a 2008. Secretaría de Salud, 2008 (Accessed Julio 1 2010). Available from: www.sinais.salud.gob.mx/descargas/xls/m_009.xls
3. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systema tic review of 118 studies. J Hepatol 2006; 44: 217-31
4. Stewart CA, Malinchoc M, Kim WR, Kamath PS. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl 2007; 13: 1366-71
5. Poordad FF. Review article: the burden of hepatic encepha lopathy. Aliment Pharmacol Ther 2007; 25(Suppl. 1): 3-9
6. Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR. Pre valence and natural history of subclinical hepatic ence phalopathy in cirrhosis. J Gastroenterol Hepatol 2001; 16: 531-5
7. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy pre dicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96: 2718-23
8. Hartmann IJ, Groeneweg M, Quero JC, et al. The prognos tic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 2000; 95: 2029-34
9. Li YY, Nie YQ, Sha WH, et al. Prevalence of subclinical he patic encephalopathy in cirrhotic patients in China. World J Gastroenterol 2004; 10: 2397-401
10. Groeneweg M, Quero JC, De Bruijn I, et al. Subclinical he patic encephalopathy impairs daily functioning. Hepatolo gy 1998; 28: 45-9
11. Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal he patic encephalopathy impairs fitness to drive. Hepatology 2004; 39: 739-45
12. Romero-Gomez M, Grande L, Camacho I. Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy. Hepatology 2004; 39: 939-43
13. Romero-Gomez M, Grande L, Camacho I, Benitez S, Irles JA, Castro M. Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with mini mal hepatic encephalopathy. J Hepatol 2002; 37: 781-7
14. Amodio P, Del Piccolo F, Marchetti P, et al. Clinical featu res and survivial of cirrhotic patients with subclinical cog nitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 1999; 29: 1662-7
15. Dhiman RK, Kurmi R, Thumburu KK, et al. Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci 2010; 55: 2381-90
16. Bajaj JS, Etemadian A, Hafeezullah M, Saeian K. Testing for minimal hepatic encephalopathy in the United States: An AASLD survey. Hepatology 2007; 45: 833-4
17. McCrea M, Cordoba J, Vessey G, Blei AT, Randolph C. Neu ropsychological characterization and detection of subclini cal hepatic encephalopathy. Arch Neurol 1996; 53: 758-63
18. Romero Gomez M, Cordoba J, Jover R, et al. Normality ta bles in the Spanish population for psychometric tests used in the diagnosis of minimal hepatic encephalopathy. Med Clin 2006; 127: 246-9
19. Sharma P, Sharma BC, Puri V, Sarin SK. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol 2007; 47: 67-73
20. Sharma P, Sharma BC, Sarin SK. Critical flicker frequency for diagnosis and assessment of recovery from minimal he patic encephalopathy in patients with cirrhosis. Hepato biliary Pancreat Dis Int 2010; 9: 27-32
21. Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Haussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 2002; 35: 357-66.
22. Romero-Gomez M, Cordoba J, Jover R, et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007; 45: 879-85
23. Romero-Gomez M. Critical flicker frequency: it is time to break down barriers surrounding minimal hepatic ence phalopathy. J Hepatol 2007; 47: 10-1
24. Conn HO, Leevy CM, Vlahcevic ZR, et al. Comparison of lactulose and neomycin in the treatment of chronic portal systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977; 72: 573-83
25. Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal he patic encephalopathy in patients with cirrhosis. Hepato logy 2004; 39: 1441-9
26. Czaja AJ, Freese DK. Diagnosis and treatment of autoim mune hepatitis. Hepatology 2002; 36: 479-97
27. Sanyal AJ, Banas C, Sargeant C, et al. Similarities and di fferences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology 2006; 43: 682-9
28. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Batt le EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characte rization and risk factors for underlying disease. Hepatology 1999; 29: 664-9
29. Secretaría de Educación Pública. Educación por niveles. 2010 (Accessed 1 de Julio, 2010). Available from: http://www.sep.gob.mx/wb/sep1/educacion_por_niveles
30. Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007; 45: 549-59
31. Groeneweg M, Moerland W, Quero JC, Hop WC, Krabbe PF, Schalm SW. Screening of subclinical hepatic encephalopa thy. J Hepatol 2000; 32: 748-53
32. Mendez-Sanchez N, Villa AR, Chavez-Tapia NC, et al. Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data. Ann Hepatol 2005; 4: 52-5
33. Jover R, Company L, Gutierrez A, et al. Minimal hepa tic encephalopathy and extrapyramidal signs in pa tients with cirrhosis. Am J Gastroenterol 2003; 98: 1599-604
34. Reichenbach A, Fuchs U, Kasper M, el-Hifnawi E, Eckstein AK. Hepatic retinopathy: morphological features of retinal glial (Muller) cells accompanying hepatic failure. Act Neu ropathol 1995; 90: 273-81